NCT06526065Recruiting
Molecular Mechanisms in Malignant Lymphoma- Predict (MMML Predict)
Molecular Mechanisms in Malignant Lymphoma- Predict
Source: ClinicalTrials.gov · Last updated 29 Jul 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The trial aims at the construction and validation of an accurate, affordable and simple prognostic tool to be used in everyday clinical practice, which allows the early and reliable identification of DLBCL patients who have a very high risk of treatment failure following R-CHOP/-like first-line therapy.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 500 (estimated)
- First submitted
- 23 Jul 2024
- Start date
- 20 Jun 2024
- Primary completion date
- 1 Jun 2026
- Lead sponsor
- University Medical Center Goettingen
- Diseases
- Diffuse large B-cell lymphoma
- NCT number
- NCT06526065
What you commit to
- Study type: Observational
- Planned participants: 500
- From 20 Jun 2024 to the primary completion date, 1 Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Treatment with R-CHOP/-like regimens already started
Other illness
- Active HIV-infection
- Presence history of other active cancers (with the exception of basal cell carcinoma of the skin)
Other
- Relationship of dependence/ direct employment with the investigator
Who the study is looking for
- Histological diagnosis of DLBCL\&LBCL
- Planned treatment with guideline-based first-line therapy
- Patient's consent
- All genders, Patient age ≥ 18 years
- Ability to consent
Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Universitätsmedizin Göttingen Coordinator of this site? Confirm its status | Göttingen | Germany | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.